Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

PROCEPT BioRobotics Q3 EPS $(0.38) Beats $(0.40) Estimate, Sales $83.327M Beat $80.943M Estimate

Author: Benzinga Newsdesk | November 04, 2025 04:05pm
PROCEPT BioRobotics (NASDAQ:PRCT) reported quarterly losses of $(0.38) per share which beat the analyst consensus estimate of $(0.40) by 5.94 percent. This is a 5 percent increase over losses of $(0.40) per share from the same period last year. The company reported quarterly sales of $83.327 million which beat the analyst consensus estimate of $80.943 million by 2.95 percent. This is a 42.76 percent increase over sales of $58.370 million the same period last year.

Posted In: PRCT


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist